
Analysis-Trump health policy uncertainty sends biotech sector into deeper slump
By Maggie Fick and Bhanvi SatijaLONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they will have a harder time getting products approved, investors, company executives and analysts said. Mass firings at the U.S. Food and Drug Administration are particularly ris ...